| |
| |
|
| Insider
Information: |
Hawkins Richard J |
| Relationship: |
Chief Executive Office... |
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
788,335 |
|
|
Indirect Shares
|
4,469 |
|
|
| Direct
Value |
$2,448,784 |
|
|
|
Indirect Value
|
$13,496 |
|
|
| Total
Shares |
792,804 |
|
|
| Total
Value |
$2,462,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -51.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Plus Therapeutics Inc |
PSTV |
Director |
2023-03-03 |
1 |
2009-04-30 |
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2017-10-13 |
0 |
2014-09-29 |
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
35,241 |
2019-05-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Executive Office... |
2024-04-01 |
753,093 |
2024-04-01 |
4,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2024-04-01 |
4 |
D |
$2.84 |
$4,322 |
D/D |
(1,522) |
753,093 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2024-04-01 |
4 |
A |
$2.84 |
$12,780 |
D/D |
4,500 |
754,615 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
D |
$3.01 |
$2,077 |
D/D |
(690) |
750,115 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
35,241 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-11 |
4 |
OE |
$0.82 |
$8,890 |
D/D |
10,841 |
12,741 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2023-03-03 |
4 |
B |
$1,000.00 |
$1,000 |
D/D |
1 |
1 |
2.31 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2023-02-01 |
4 |
D |
$3.52 |
$1,464 |
D/D |
(416) |
752,327 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2023-02-01 |
4 |
A |
$3.52 |
$15,840 |
D/D |
4,500 |
752,743 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-07 |
4 |
OE |
$0.65 |
$762 |
D/D |
1,172 |
1,900 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-09-23 |
4 |
B |
$8.80 |
$1,830 |
I/I |
208 |
4,469 |
2.58 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-09-21 |
4 |
B |
$8.84 |
$19,572 |
I/I |
2,214 |
4,261 |
2.58 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-09-20 |
4 |
B |
$8.75 |
$13,178 |
I/I |
1,506 |
2,047 |
2.58 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-09-19 |
4 |
B |
$8.65 |
$4,680 |
I/I |
541 |
541 |
2.58 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-04-01 |
4 |
D |
$9.23 |
$13,531 |
D/D |
(1,466) |
748,243 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-02-01 |
4 |
D |
$10.02 |
$1,733 |
D/D |
(173) |
749,709 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2022-02-01 |
4 |
A |
$10.02 |
$45,090 |
D/D |
4,500 |
749,882 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-13 |
4 |
OE |
$0.55 |
$400 |
D/D |
728 |
728 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,329 |
746,904 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Executive Officer |
• • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
744,575 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-05-15 |
4 |
S |
$11.16 |
$116,167 |
D/D |
(10,409) |
0 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-05-14 |
4 |
S |
$11.07 |
$161,455 |
D/D |
(14,591) |
10,409 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-05-14 |
4 |
OE |
$0.52 |
$13,013 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2017-10-13 |
4 |
D |
$11.18 |
$272,378 |
D/D |
(24,363) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-08-12 |
4 |
S |
$10.37 |
$1,244,724 |
D/D |
(120,000) |
24,363 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2016-08-12 |
4 |
OE |
$1.75 |
$288,000 |
D/D |
120,000 |
54,363 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
